{"title":"A new humanized pig model","authors":"Alexandra Le Bras","doi":"10.1038/s41684-025-01591-8","DOIUrl":null,"url":null,"abstract":"<p>Humanized mice engrafted with human hematopoietic stem and progenitor cells (HSPCs) are valuable models for exploring human immunology. However, the small size and short lifespan of the mouse models limit their translational value. Pigs are suitable large animal models for preclinical research, but existing immunodeficient pig models show limited human HSPC engraftment and multilineage differentiation. A new study reports the development of an immunodeficient pig model that supports robust human HSPC engraftment and blood cell formation, offering a valuable preclinical tool for studying human immunology. The researchers used CRISPR-Cas9 technology to inactivate <i>RAG1</i> and <i>IL2RG</i> in Bama pig fibroblasts and generated the immunodeficient pigs via somatic cell nuclear transfer and embryo transfer. The team also deleted <i>CD47</i>, a gene encoding a cell surface protein that regulates macrophage-mediated phagocytosis with the aim of preventing rejection of human cells by pig macrophages. Using multiple approaches to characterize human cell development in the engineered pigs, the researchers found that the triple-knockout pigs (<i>RAG2/IL2RG/CD47</i>) showed long-term human HSPC engraftment in the bone marrow, robust thymopoiesis and T cell development in the thymus, and repopulation with multilineage human hematopoietic cells throughout tissues.</p><p><b>Original reference:</b> Hu, Z. et al<i>. Nat. Biomed. Eng</i>. https://doi.org/10.1038/s41551-025-01397-6 (2025)</p>","PeriodicalId":17936,"journal":{"name":"Lab Animal","volume":"5 1","pages":""},"PeriodicalIF":3.9000,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lab Animal","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.1038/s41684-025-01591-8","RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Humanized mice engrafted with human hematopoietic stem and progenitor cells (HSPCs) are valuable models for exploring human immunology. However, the small size and short lifespan of the mouse models limit their translational value. Pigs are suitable large animal models for preclinical research, but existing immunodeficient pig models show limited human HSPC engraftment and multilineage differentiation. A new study reports the development of an immunodeficient pig model that supports robust human HSPC engraftment and blood cell formation, offering a valuable preclinical tool for studying human immunology. The researchers used CRISPR-Cas9 technology to inactivate RAG1 and IL2RG in Bama pig fibroblasts and generated the immunodeficient pigs via somatic cell nuclear transfer and embryo transfer. The team also deleted CD47, a gene encoding a cell surface protein that regulates macrophage-mediated phagocytosis with the aim of preventing rejection of human cells by pig macrophages. Using multiple approaches to characterize human cell development in the engineered pigs, the researchers found that the triple-knockout pigs (RAG2/IL2RG/CD47) showed long-term human HSPC engraftment in the bone marrow, robust thymopoiesis and T cell development in the thymus, and repopulation with multilineage human hematopoietic cells throughout tissues.
Original reference: Hu, Z. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-025-01397-6 (2025)
期刊介绍:
LabAnimal is a Nature Research journal dedicated to in vivo science and technology that improves our basic understanding and use of model organisms of human health and disease. In addition to basic research, methods and technologies, LabAnimal also covers important news, business and regulatory matters that impact the development and application of model organisms for preclinical research.
LabAnimal's focus is on innovative in vivo methods, research and technology covering a wide range of model organisms. Our broad scope ensures that the work we publish reaches the widest possible audience. LabAnimal provides a rigorous and fair peer review of manuscripts, high standards for copyediting and production, and efficient publication.